Meta-analysis of neoadjuvant immunotherapy for non-metastatic colorectal cancer

BACKGROUND: Immunotherapy has been approved for the treatment of metastatic colorectal cancer. The efficacy and safety of neoadjuvant immunotherapy for the treatment of non-metastatic colorectal cancer remains unclear. We tried to explore clinical effect of neoadjuvant immunotherapy in the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Long, Yang, Xiao-Quan, Zhao, Guang-yue, Wang, Feng-jian, Liu, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911889/
https://www.ncbi.nlm.nih.gov/pubmed/36776899
http://dx.doi.org/10.3389/fimmu.2023.1044353

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911889/
https://www.ncbi.nlm.nih.gov/pubmed/36776899
http://dx.doi.org/10.3389/fimmu.2023.1044353

Ejemplares similares